| SIRT1 is essential for normal cognitive function and synaptic plasticity S Michán, Y Li, MMH Chou, E Parrella, H Ge, JM Long, JS Allard, K Lewis, ... Journal of Neuroscience 30 (29), 9695-9707, 2010 | 601 | 2010 |
| Life span extension by calorie restriction depends on Rim15 and transcription factors downstream of Ras/PKA, Tor, and Sch9 M Wei, P Fabrizio, J Hu, H Ge, C Cheng, L Li, VD Longo PLoS genetics 4 (1), e13, 2008 | 585 | 2008 |
| FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution H Ge, K Liu, T Juan, F Fang, M Newman, W Hoeck Bioinformatics 27 (14), 1922-1928, 2011 | 311 | 2011 |
| Tor1/Sch9-regulated carbon source substitution is as effective as calorie restriction in life span extension M Wei, P Fabrizio, F Madia, J Hu, H Ge, LM Li, VD Longo PLoS genetics 5 (5), e1000467, 2009 | 251 | 2009 |
| OSA: a fast and accurate alignment tool for RNA-Seq J Hu, H Ge, M Newman, K Liu Bioinformatics 28 (14), 1933-1934, 2012 | 142 | 2012 |
| Inference of transcription modification in long-live yeast strains from their expression profiles C Cheng, P Fabrizio, H Ge, VD Longo, LM Li BMC genomics 8, 1-10, 2007 | 61 | 2007 |
| Significant and systematic expression differentiation in long-lived yeast strains C Cheng, P Fabrizio, H Ge, M Wei, VD Longo, LM Li PLoS One 2 (10), e1095, 2007 | 32 | 2007 |
| Comparative analyses of time-course gene expression profiles of the long-lived sch9Δ mutant H Ge, M Wei, P Fabrizio, J Hu, C Cheng, VD Longo, LM Li Nucleic acids research 38 (1), 143-158, 2010 | 26 | 2010 |
| Haploinsufficiency of the insulin receptor in the presence of a splice-site mutation in Ppp2r2a results in a novel digenic mouse model of type 2 diabetes M Goldsworthy, Y Bai, CM Li, H Ge, E Lamas, H Hilton, CT Esapa, ... Diabetes 65 (5), 1434-1446, 2016 | 25 | 2016 |
| Limited differential expression of miRNAs and other small RNAs in LPS-stimulated human monocytes D Lu, T Yamawaki, H Zhou, WY Chou, M Chhoa, E Lamas, SS Escobar, ... PloS one 14 (3), e0214296, 2019 | 14 | 2019 |
| RNA-seq analysis pipeline based on oshell environment J Li, J Hu, M Newman, K Liu, H Ge IEEE/ACM transactions on computational biology and bioinformatics 11 (5 …, 2014 | 11 | 2014 |
| Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicity JR Lydeard, MI Lin, HG Ge, A Halfond, S Wang, MB Jones, J Etchin, ... Molecular Therapy Methods & Clinical Development 31, 2023 | 9 | 2023 |
| A probe-treatment-reference (PTR) model for the analysis of oligonucleotide expression microarrays H Ge, C Cheng, LM Li BMC bioinformatics 9, 1-11, 2008 | 8 | 2008 |
| Systems and methods for analyzing microarrays LM Li, C Cheng, H Ge US Patent 8,340,915, 2012 | 5 | 2012 |
| P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML … J Xavier-Ferrucio, C Luo, G Angelini, S Krishnamurthy, N Patel, M Pettiglio, ... Hemasphere 6, 1312-1313, 2022 | 2 | 2022 |
| G-CSF/Plerixafor Dual-Mobilized Donor Derived CD33CAR T-Cells as Potent and Effective AML Therapy in Pre-Clinical Models G Canesin, H Hoyt, R Williams, M Silva, M Chng, C Cummins, M Ung, ... Blood 138, 1716, 2021 | 2 | 2021 |
| Multimodal Atlas of Paired Diagnosis and Relapse AML Samples Enables Novel Therapeutic Targeting of Surface Antigens A Halfond, M Ung, J Etchin, Y Keschner, J DiFazio, A Pyclik, ... Blood 142, 164, 2023 | 1 | 2023 |
| Knock out of CD123 or CLL-1 By CRISPR-Cas9 Editing from Human Hematopoietic Stem Cell Transplants Provide New Possibilities for Increasing Therapeutic Index and Safety for AML … C Luo, G Angelini, S Krishnamurthy, J Lisle, M Isik, A Ghdossi, ... Blood 138, 3818, 2021 | 1 | 2021 |
| VOR33: A Clinic-Ready CRISPR/Cas9 Engineered Hematopoietic Stem Cell Transplant for the Treatment of Acute Myeloid Leukemia J Lydeard, M Lin, C Luo, S Wang, A Halfond, MB Jones, J Scherer, ... Molecular Therapy, 2021 | 1 | 2021 |
| Rigorous Assessment of Off-Target Editing by CRISPR/Cas9 in VOR33, an Engineered Hematopoietic Stem Cell Transplant for the Treatment of Acute Myeloid Leukemia D Hazelbaker, M Isik, A Ghodssi, M Ung, A Halfond, S Wang, K Cummins, ... Molecular Therapy 29 (4), 408-409, 2021 | 1 | 2021 |
Valter D. LongoUSC, IFOMVerified email at usc.edu
